Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?GuruFocus · 4 days ago
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)GlobeNewsWire · 4 days ago
Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?GuruFocus · 6 days ago
Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?PRNewsWire · 6 days ago
Cencora (NYSE:COR) and Option Care Health (NASDAQ:OPCH) Financial ContrastDefense World · Oct 17, 2026
OPCH Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Option Care Health to CD&R and McKessonGlobeNewsWire · Oct 13, 2026Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 29, 2026 | $0.43 | $0.45 | Beat |
| Apr 30, 2026 | $0.37 | $0.40 | Beat |
| Feb 24, 2026 | $0.46 | $0.46 | Beat |
| Oct 30, 2025 | $0.43 | $0.45 | Beat |
| Jul 30, 2025 | $0.40 | $0.41 | Beat |
| Apr 29, 2025 | $0.36 | $0.40 | Beat |